Cơ Chế Tác Dụng :
EHT 0202 is developed to treat neurodegenerative disorders by ExonHit Therapeutics.
EHT 0202 was discovered to play a role in protecting neurons in pharmacological models of neuronal cell death. ExonHit identified RNA isoforms produced by alterations of splicing specifically taking place in neurodegenerative disease models. These isoforms were identified using DATAS(TM), ExonHit's proprietary gene profiling technology. DATAS(TM), stands for Differential Analysis of Transcripts with Alternative Splicing.
Chỉ Định :
Investigated for use/treatment in alzheimer's disease and neurologic disorders.